By writer to www.eurekalert.org
Beneath please discover a abstract and hyperlink(s) of latest coronavirus-related content material revealed in the present day in Annals of Inside Drugs. The abstract beneath just isn’t meant to substitute for the total article as a supply of knowledge. A set of coronavirus-related content material is free to the general public at http://go.
1. Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient with COVID-19
Research counsel that many sufferers with COVID-19 and acute respiratory misery syndrome expertise a cytokine storm characterised by fever; hyperferritinemia; and a large launch of inflammatory cytokines, together with interleukin-6, tumor necrosis factor-α, and monocyte chemoattractant proteins. These findings led to the speculation that organic brokers concentrating on particular cytokine or inflammatory pathways could enhance the respiratory outcomes of sufferers with probably the most extreme types of COVID-19. Researchers from the College Hospital of Toulouse; Toulouse, France, examined this speculation on a severely in poor health affected person on a ventilator for COVID-19. They handled the affected person with tocilizumab as salvage remedy, as an alternative of etoposide, and the affected person improved dramatically. Learn the total textual content: https:/
Media contacts: A PDF for this text just isn’t but accessible. Please click on the hyperlink to learn full textual content. The lead writer, Stanislas Faguer, MD, PhD, might be reached at email@example.com.
Disclaimer: AAAS and EurekAlert! are usually not answerable for the accuracy of reports releases posted to EurekAlert! by contributing establishments or for the usage of any data by the EurekAlert system.
— to www.eurekalert.org